Keywords: Alvogen, Par pharma, Production facility, R&D, Generics

Alvogen acquires R&D capabilities and enters into multi-product development deal with Par Pharmaceutical

Article | 23 October 2009

Print This

New Jersey, USA-based Alvogen Group says that it has acquired R&D capabilities from Par Pharmaceutical. .As part of the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in